Collaborative Investment Series Trust Adaptive Core Fund RULE 深 沪
等待开盘 02-20 09:30:00 美东时间
25.4048
-0.095
-0.37%
华盛通- 最 高25.4048
- 今 开25.3893
- 成交量 1162股
- 最 低 25.31
- 昨 收 25.4997
- 总市值 1333.74万
- 52周最高 25.9184
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 18.63
- 委 比 0.00%
- 总股本 52.50万
- 历史最高 26.0986
- 量 比 0
- 振 幅 0.37%
- 历史最低 17.3402
- 每 手 1
- 风险率 1.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Glove found near Nancy Guthrie's home fails to produce DNA match
Glove found near Nancy Guthrie's home fails to produce DNA match Comparison with DNA profiles in CODIS database comes up empty Investigators analyzing other DNA samples from Guthrie residence DNA taken from glove that resembled pair worn by masked prowler By Herbert Villarraga and Steve Gorman TUCSO
02-18 07:34
Warsh may want a smaller Fed balance sheet, but that's hard to achieve
Warsh may want a smaller Fed balance sheet, but that's hard to achieve Fed nominee Warsh has been a critic of a large Fed balance sheet Experts warn shrinking Fed holdings is hard, potentially destabilizing Liquidity regulation changes could give Fed space to shrink balance sheet By Michael S. Derby
02-17 19:00
BRIEF-ANZ Seeks Trading Halt Of Securities
BRIEF-ANZ Seeks Trading Halt Of Securities Feb 12 (Reuters) - ANZ Group ANZ.AX : TRADING HALT OF SECURITIES REQUEST A TRADING HALT TO BE APPLIED TO OUR SECURITIES (ANZ) UNDER NZX LISTING RULE Further company coverage: ANZ.AX (( Reuters.Briefs@thomsonreuters.com ;))
02-12 03:37
BRIEF-FDA's Vinay Prasad Overruled Staff To Reject Moderna’s Flu Vaccine Application - Stat News
BRIEF-FDA's Vinay Prasad Overruled Staff To Reject Moderna’s Flu Vaccine Application - Stat News Feb 11 (Reuters) - FDA'S VINAY PRASAD OVERRULED STAFF TO REJECT MODERNA’S FLU VACCINE APPLICATION - STAT NEWS Source text: [ https://tinyurl.com/5a6wr3xz ] Further company coverage: MRNA.O (( Reuters.Bri
02-11 23:36
BRIEF-Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BRIEF-Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Feb 9 (Reuters) - Pacira Biosciences Inc PCRX.O : PACIRA BIOSCIENCES REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX1t1PSy Further company coverage: PCRX.O (( Reuters.Briefs@th
02-09 21:18
BRIEF-Glencore Says Rio's Bid Not In Best Interests Of Shareholders
BRIEF-Glencore Says Rio's Bid Not In Best Interests Of Shareholders Feb 5 (Reuters) - Glencore PLC GLEN.L : GLENCORE PLC - RESPONSE TO RULE 2.8 ANNOUNCEMENT FROM RIO TINTO GLENCORE - RIO TINTO WILL NOT MAKE OFFER FOR GLENCORE GLENCORE - CONCLUDED THAT PROPOSED ACQUISITION ON THESE TERMS IS NOT IN B
02-05 23:33
Warsh may struggle to lay down new rules of the road for Fed
Warsh may struggle to lay down new rules of the road for Fed Warsh's nomination seen as test for Fed's expansive role He is seen as advocate of rules but not necessarily of constraint Top Fed job will test Warsh's commitment to principles he has set By Howard Schneider WASHINGTON, Feb 5 (Reuters) -
02-05 19:00
BRIEF-RCI Receives Anticipated Nasdaq Letter
BRIEF-RCI Receives Anticipated Nasdaq Letter Feb 2 (Reuters) - RCI Hospitality Holdings Inc RICK.O : RCI RECEIVES ANTICIPATED NASDAQ LETTER RCI HOSPITALITY HOLDINGS INC - RECEIVES NASDAQ LETTER FOR NONCOMPLIANCE WITH LISTING RULE Source text: ID:nBwXTV2da Further company coverage: RICK.O (( Reuters.
02-03 06:01
BRIEF-IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BRIEF-IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Jan 30 (Reuters) - IDEAYA Biosciences Inc IDYA.O : IDEAYA BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nPn7kGbrTa Further company coverage: IDYA.O (( Reuters.Brie
01-30 19:01
BRIEF-Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
BRIEF-Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Jan 28 (Reuters) - Enveric Biosciences Inc ENVB.O : ENVERIC BIOSCIENCES ANNOUNCES CLOSING OF $1.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
01-29 07:11
